Plasma Phospholipids and Platelet Function in Uremic Patients
Ana M. Vecino(Palmetto Hematology Oncology), Jes uacute s M. Cesar(Palmetto Hematology Oncology), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Jos eacute L. Teruel(Hospital Universitario Ramón y Cajal)
Cited by 11
Related Papers
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients
|Blood|2013|189
Human immunodeficiency virus‐associated plasmablastic lymphoma
|Cancer|2012|178
Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma
|Haematologica|2007|123
Influence of highly active anti‐retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome‐related non‐Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone
|British Journal of Haematology|2001|104
Bortezomib plus <scp>EPOCH</scp> is effective as frontline treatment in patients with plasmablastic lymphoma
|British Journal of Haematology|2018|90